| Application no. and date | 17832405.9 (espacenet) (Federated) (European Patent Register), 20171214 | | Patent/reg. no. and date | DK/EP 3554554, 20220907 | | Publication date | 20191023 | | Priority no. and date | US 201662436199 P, 20161219, US 201762443481 P, 20170106, US 201762479177 P, 20170330, US 201762562119 P, 20170922 | | EP pub. no. and date |
EP 3554554 20191023 | | Effective date | | | Applicant/owner | Sarepta Therapeutics, Inc., 215 First Street, Suite 415
Cambridge, MA 02142, US | | Applicant ref. no. | 1634237 | | Inventor | PASSINI, Marco, A., 215 First Street
Suite 415
Cambridge, MA 02142, US,
HANSON, Gunnar, J., 215 First Street
Suite 415
Cambridge, MA 02142, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 47/64 (2017.01) , A61P 21/00 (2006.01) | | Title | EXON-OVERSPRINGNINGS-OLIGOMERKONJUGAT TIL MUSKELDYSTROFI | | Int. application no. | US2017066351 | | Int. publication no. | WO2018118627 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
